ABOUT
HTA works with medtech/healthtech companies from all over the world to educate them about the U.S. healthcare market, guide them in developing U.S.-focused strategic plans, facilitate pilot projects and clinical trials with our coalition of hospital and health system partners, and to help them raise investment capital from U.S. investors. We often invest directly in these companies ourselves. Our competitive advantage is our ability to provide guaranteed hospital pilot projects and clinical trials, a core competency we’ve developed over nearly a decade of building our coalition of clinical partners.
HeartX – the annual accelerator currently focused on cardiovascular technologies - guarantees at least one hospital pilot project or clinical trial for each early-stage company admitted to the program. In addition to the guaranteed pilots, participating companies receive upfront investment from the HeartX Fund.
Our accelerator targets three areas of healthcare innovation: digital health (software), medical devices and diagnostic platforms. Our program is for providers and by providers, so we seek technologies that can improve our providers’ operations by improving quality of care, enhancing efficiencies, reducing costs, etc. In fact, our clinical partners choose the companies invited to participate in the program each year.
Our accelerator is virtual, so there’s no requirement to be onsite other than to be with your clinical partners just as you would to facilitate any other pilot project or clinical trial. In addition to the guaranteed pilots, participating companies receive upfront investment capital through a SAFE or convertible note based on the company’s current valuation.
Applications for 2026 will open in February 2026.
CLINICAL PARTNERS
OUR TEAM
Jeff Stinson
Director
Dr. Amy Hester
Clinician-in-Residence
Haley McCarver
Director of Operations
Dr. Jason Beck
Entrepreneur-in-Residence
Emily Dean
Marketing Support
Dr. Jay Gandy
Entrepreneur-in-Residence